Archivos argentinos de pediatría
-
Arch Argent Pediatr · Apr 2009
Clinical Trial[Levosimendan, a new inotropic drug: experience in children with acute heart failure].
Low cardiac output syndrome occurs frequently in pediatric patients after cardiac surgery. Catecholamines are used as inotropic drugs to treat this threatening condition, but may cause undesirable and potentially harmful side effects. This study was performed to evaluate the efficacy and safety of levosimendan (LEVO) in pediatric patients with low cardiac output syndrome. ⋯ LEVO improved cardiac output in 50% of the interventions with post-surgical LCOS and no adverse effect was observed.